Thus, we propose that hypoxia upregulates the expression of Nox4 via the TGF-β/Smad pathway and increases ROS production and therapies targeting Nox4 may be effective against hypoxia-induced acute kidney injury. This evidence concerns the gene TGFB1 and acute kidney injury.